Bsteh, G; Hegen, H; Riedl, K; Altmann, P; Auer, M; Berek, K; Di Pauli, F; Ehling, R; Kornek, B; Monschein, T; Rinner, W; Schmied, C; Wurth, S; Zinganell, A; Zulehner, G; Zrzavy, T; Deisenhammer, F; Rommer, P; Leutmezer, F; Berger, T.
Quantifying the risk of disease reactivation after dmt discontinuation - the viaadisc score.
MULT SCLER J. 2020; 26(3_SUPPL): 300-300.
[Poster]
Web of Science